✦ LIBER ✦

W1281 The Phase I Safety and Feasibility Results of Autologous Intravenous Mesenchymal Stromal Cell Treatment in Refractory Crohn's Disease

✍ Scribed by Duijvestein, Marjolijn; Wildenberg, Manon E.; Wendrich, Barbara B.; Vos, Anne Christine W.; Verhaar, Auke; Fidder, Herma H.; Roelofs, Helene; Zwaginga, Jaap Jan; Fibbe, Willem E.; van den Brink, Gijs R.; Hommes, Daniel W.

Book ID: 123188179
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 49 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63172-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S40 Phase I results of intravenous autol

S40 Phase I results of intravenous autologous bone marrow derived mesenchymal stromal cell treatment in refractory Crohn's disease

✍ M. Duijvestein; M.E. Wildenberg; A.C. Vos; A.P. Verhaar; H.H. Fidder; J.J. Zwagi 📂 Article 📅 2010 🏛 Oxford University Press ⚖ 59 KB

Autologous bone marrow-derived mesenchym

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

✍ Duijvestein, Marjolijn (author);Vos, Anne Christine W. (author);Roelofs, Helene 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 593 KB

Autologous bone marrow-derived mesenchym

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

✍ Duijvestein, Marjolijn (author);Vos, Anne Christine W. (author);Roelofs, Helene 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 593 KB

Allogeneic dendritic cell (DC) vaccinati

Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study

✍ Tanja de Gruijl,Saskia Santegoeds… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 66 KB